Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 6/20 | 0.73 |
| ▸ | MAOA | P21397 | 5/20 | 0.73 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.73 |
| ▸ | SDHA | P31040 | 2/20 | 0.73 |
| ▸ | LMNA | P02545 | 1/20 | 0.73 |
| ▸ | CALML3 | P27482 | 1/20 | 0.73 |
| ▸ | F10 | P00742 | 9/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL5727900 | 1.00 | MAOB (0.73) | MAOBMAOAPTGS1SDHALMNA | |
| Trifluoroacetic Acid SCHEMBL6509850 | 1.00 | MAOB (0.73) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL1498511 | 0.95 | MAOA (0.80) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL1894257 | 0.95 | MAOA (0.80) | MAOBMAOAPTGS1SDHALMNA | |
| Hydrochloric Acid SCHEMBL4689047 | 0.94 | MAOA (0.79) | MAOBMAOAPTGS1SDHALMNA | |
| Hydrochloric Acid SCHEMBL4689051 | 0.94 | MAOA (0.79) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL5818098 | 0.91 | MAOA (0.75) | MAOBMAOAPTGS1SDHALMNA | |
| Phosphonic Acid SCHEMBL5325175 | 0.91 | MAOB (0.75) | MAOBMAOAPTGS1SDHALMNA | |
| Trifluoroacetic Acid SCHEMBL6528038 | 0.91 | MAOA (0.67) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL10151522 | 0.89 | MAOA (0.80) | MAOBMAOAPTGS1SDHALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060293307-A1 | Oxazolidinone derivatives as antimicrobials | RANBAXY LABORATORIES LIMITED (IN) | 2006-12-28 | — | — | US | disclosed |
| WO-2005082899-A1 | OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS | RANBAXY LABORATORIES LIMITED (IN) | 2005-09-09 | — | — | WO | disclosed |
| EP-0918770-A1 | PYRIDYL-PIPERAZINYL-PHENYL-OXAZOLIDINONE DERIVATIVES AND THEIR USE AS ANTIBACTERIALS | AstraZeneca AB (SE) | 1999-06-02 | — | — | EP | disclosed |
| EP-0918769-A1 | SUBSTITUTED PIPERAZINYL-PHENYL-OXAZOLIDINONE DERIVATIVES AND THEIR USE AS ANTI-BACTERIAL AGENTS | AstraZeneca AB (SE) | 1999-06-02 | — | — | EP | disclosed |
| WO-1998001447-A1 | PYRIDYL-PIPERAZINYL-PHENYL-OXAZOLIDINONE DERIVATIVES AND THEIR USE AS ANTIBACTERIALS | ZENECA LIMITED (GB) | 1998-01-15 | — | — | WO | disclosed |
| WO-1998001446-A1 | SUBSTITUTED PIPERAZINYL-PHENYL-OXAZOLIDINONE DERIVATIVES AND THEIR USE AS ANTI-BACTERIAL AGENTS | ZENECA LIMITED (GB) | 1998-01-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060293307-A1 | Oxazolidinone derivatives as antimicrobials | OXA1L, PDK4, SDHA | MAOB 1976/4885MAOA 1568/4885PTGS1 3175/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.